首页> 外文期刊>Biomacromolecules >Synthesis of Poly(lactide-co-glycolide-co-ε-caprolactone)-graft-mannosylated Poly(ethylene oxide) Copolymers by Combination of 'Clip' and 'Click' Chemistries
【24h】

Synthesis of Poly(lactide-co-glycolide-co-ε-caprolactone)-graft-mannosylated Poly(ethylene oxide) Copolymers by Combination of 'Clip' and 'Click' Chemistries

机译:结合“夹子”和“点击”化学方法合成丙交酯-乙交酯-乙交酯-ε-己内酯-接枝-甘露糖基化的聚环氧乙烷共聚物

获取原文
获取原文并翻译 | 示例
           

摘要

Poly(lactide-co-glycolide) (PLGA) is extensively used in pharmaceutical applications, for example, in targeted drug delivery, because of biocompatibility and degradation rate, which is easily tuned by the copolymer composition. Nevertheless, synthesis of sugar-labeled amphiphilic copolymers with a PLGA backbone is quite a challenge because of high sensitivity to hydrolytic degradation. This Article reports on the synthesis of a new amphiphilic copolymer of PLGA grafted by mannosylated poly(ethylene oxide) (PEO), A novel building block, that is, α-methoxy-ω-alkyne PEO-dip-N-hydroxysuccinimide (NHS) ester, was prepared on purpose by photoreaction of a diazirine containing molecular clip. This PEO block was mannosylated by reaction of the NHS ester groups with an aminated sugar, that is, 2-aminoethyl-α-D-mannopyroside. Then, the alkyne co-end-group of PEO was involved in a copper alkyne- azide coupling (CuAAC) with the pendent azides of the aliphatic copolyester. The targeted mannose-labeled poly(lactide-co-glycolide-co-ε-caprolactone)-graft-poly(ethylene oxide) copolymer was accordingly formed, Copolymerization of D,L-lactide and glycolide with α-chloro-ε-caprolactone, followed by substitution of chlorides by azides provided the azido-functional PLGA backbone. Finally, micelles of the amphiphilic mannosylated graft copolymer were prepared in water, and their interaction with Concanavalin A (ConA), a glyco-receptor protein, was studied by quartz crystal microbalance. This study concluded to the prospect of using this novel bioconjugate in targeted drug delivery.
机译:聚(丙交酯-共-乙交酯)(PLGA)由于其生物相容性和降解速率而广泛地用于药物应用中,例如在靶向药物递送中,其易于通过共聚物组合物进行调节。然而,由于对水解降解的高敏感性,合成具有PLGA主链的糖标记的两亲共聚物是一个很大的挑战。本文报道了由甘露糖基化的聚环氧乙烷(PEO)接枝的新型PLGA两亲共聚物的合成,这是一种新型结构单元,即α-甲氧基-ω-炔烃PEO-dip-N-羟基琥珀酰亚胺(NHS)通过含有二嗪的分子夹子的光反应,有目的地制备了这种酯。该PEO嵌段通过NHS酯基团与胺化糖即2-氨基乙基-α-D-甘露糖苷反应而被甘露糖基化。然后,PEO的炔烃共-端基与脂族共聚酯的侧链叠氮化物参与铜炔烃-叠氮化物偶联(CuAAC)。由此形成目标甘露糖标记的聚(丙交酯-乙交酯-共-ε-己内酯)-接枝-聚环氧乙烷共聚物,D,L-丙交酯和乙交酯与α-氯-ε-己内酯的共聚,然后用叠氮化物取代氯化物,提供了叠氮基官能PLGA主链。最后,在水中制备了两亲性甘露糖基化接枝共聚物的胶束,并通过石英晶体微量天平研究了它们与糖受体蛋白伴刀豆球蛋白A(ConA)的相互作用。这项研究总结了在靶向药物递送中使用这种新型生物缀合物的前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号